Cathepsin K Market Key Players – Mateon Therapeutics Inc, Medivir AB, Sanofi, Virobay Inc Analysis & Forecast 2018 to 2022 with their unique quality of simplifying the market research study, presents a deep diving study report “Cathepsin K – Pipeline Review, H1 2018”

Cathepsin K


Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC – Cathepsin K or CTSK is an enzyme encoded by CTSK gene. It is closely involved in osteoclastic bone resorption and participates partially in the disorder of bone remodeling. It plays an important role in extracellular matrix degradation. The enzyme is ability to catabolize elastin, collagen, and gelatin allow it to break down bone and cartilage.


Click here for sample report @


Top Companies mentioned

Mateon Therapeutics Inc

Medivir AB


Virobay Inc


Cathepsin K Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Cathepsin K  – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Cathepsin K , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC targeted therapeutics development with respective active and dormant or discontinued projects. Currently, the molecules developed by companies in Phase II, Preclinical and Discovery stages are 1, 1 and 3 respectively.

Cathepsin K pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Cathepsin K – Competitive Analysis

Key players are making innovative developments in Cathepsin K industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Cathepsin K.

The pipeline guide reviews pipeline therapeutics for Cathepsin K by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Cathepsin K therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Cathepsin K therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Cathepsin K.


For Detailed Reading Please visit @

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Leave a Reply

Your email address will not be published. Required fields are marked *

Designed by
Powered by